Antiphospholipid antibodies in patients with eosinophilia myalgia and toxic oil syndrome. 1997

P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
Rheumatology Department, Hospital 12 de Octubre, Madrid, Spain.

OBJECTIVE To explore whether antiphospholipid antibodies (aPL) are markers of vascular related damage or merely evidence of toxic related autoimmunity, we investigated the presence of different aPL in patients with toxic oil syndrome (TOS) and compared the profile with patients with eosinophilia myalgia syndrome (EMS). METHODS Reactivity against cardiolipin, P-serine, P-inositol, and P-choline was investigated by ELISA in the blood of 266 patients with acute and chronic TOS, 25 healthy relatives of TOS patients, and 48 patients with EMS. RESULTS 32% of TOS and 13% of EMS patients had IgG antibodies against cardiolipin and other polyanions. 20% of both TOS and EMS patients presented IgM antibodies against anionic and zwitterionic phospholipids. 36% of TOS healthy relatives had IgM antibodies against differently charged phospholipids. Among 200 patients with chronic TOS, there was no significant association between antibodies and clinical manifestations. CONCLUSIONS aPL with different specificity are present in a high percentage of patients with TOS and EMS. The significance of these antibodies remains unclear.

UI MeSH Term Description Entries
D010938 Plant Oils Oils derived from plants or plant products. Oils, Plant,Oils, Vegetable,Plant Oil,Vegetable Oil,Vegetable Oils,Oil, Plant,Oil, Vegetable
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005229 Fatty Acids, Monounsaturated Fatty acids which are unsaturated in only one position. Monounsaturated Fatty Acid,Acid, Monounsaturated Fatty,Acids, Monounsaturated Fatty,Fatty Acid, Monounsaturated,Monounsaturated Fatty Acids
D005517 Foodborne Diseases Acute illnesses, usually affecting the GASTROINTESTINAL TRACT, brought on by consuming contaminated food or beverages. Most of these diseases are infectious, caused by a variety of bacteria, viruses, or parasites that can be foodborne. Sometimes the diseases are caused by harmful toxins from the microbes or other chemicals present in the food. Especially in the latter case, the condition is often called food poisoning. Food Poisoning,Food-borne Disease,Food-borne Illness,Foodborne Disease,Foodborne Illness,Food-borne Diseases,Food-borne Illnesses,Foodborne Illnesses,Poisoning, Food,Disease, Food-borne,Disease, Foodborne,Food Poisonings,Food borne Disease,Food borne Diseases,Food borne Illness,Food borne Illnesses,Illness, Food-borne,Illness, Foodborne,Illnesses, Foodborne
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074262 Rapeseed Oil PLANT OILS derived from RAPESEED species known as BRASSICA NAPUS. Canadian Oil,Canola Oil,LEAR Oil,Low Erucic Acid Rapeseed Oil,Oil, Canadian,Oil, Canola,Oil, LEAR,Oil, Rapeseed
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes
D016603 Eosinophilia-Myalgia Syndrome A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93) Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related,L-Tryptophan-Related Eosinophilia-Myalgia Syndrome,Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related,Eosinophilia Myalgia Syndrome,Eosinophilia-Myalgia Syndromes,Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related,L-Tryptophan-Related Eosinophilia-Myalgia Syndromes,Syndrome, Eosinophilia-Myalgia,Syndrome, L-Tryptophan-Related Eosinophilia-Myalgia,Syndromes, Eosinophilia-Myalgia,Syndromes, L-Tryptophan-Related Eosinophilia-Myalgia
D017152 Antibodies, Antiphospholipid Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with certain autoimmune diseases (e.g., SYSTEMIC LUPUS ERYTHEMATOSUS and ANTIPHOSPHOLIPID SYNDROME), some non-autoimmune diseases, and also in healthy individuals. Antiphospholipid Antibodies,Antiphospholipid Autoantibodies,Antiphospholipid Autoantibody,Phospholipid Autoantibodies,Phospholipid Autoantibody,Antiphospholipid Antibody,Antibody, Antiphospholipid,Autoantibody, Antiphospholipid,Autoantibody, Phospholipid

Related Publications

P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
January 2001, Ryoikibetsu shokogun shirizu,
P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
November 1993, Current opinion in rheumatology,
P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
November 1995, Current opinion in rheumatology,
P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
November 1994, Current opinion in rheumatology,
P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
December 1992, Current opinion in rheumatology,
P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
August 1993, Mayo Clinic proceedings,
P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
January 1996, Advances in experimental medicine and biology,
P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
October 1993, The Journal of rheumatology,
P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
January 1994, Archives of dermatology,
P E Carreira, and M G Montalvo, and L D Kaufman, and R M Silver, and M Izquierdo, and J J Gomez-Reino
December 1994, The Journal of rheumatology,
Copied contents to your clipboard!